Kevin Forrest serves as Executive at Cidara Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kevin Forrest has executed 3 insider transactions totaling $247.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 31, 2017 involved purchasing 12,500 shares valued at $96.9K.
Kevin Forrest currently holds 72,354 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Forrest has been a net buyer of CDTX stock. They have purchased $247.9K and sold $0 worth of shares.
Kevin Forrest's most recent insider trade was on Mar 31, 2017, when they purchased 12,500 shares at $7.75 per share.
Get notified when new Form 4 filings are submitted
| $11.53 |
| Discretionary |
| Nov 23, 2015 | CDTX | $100.8K | Purchase | 7,087 | $14.23 | Discretionary |